ESC 365 - The effects of combined hyperbaric oxygenation and erythropoietin therapy in treatment of heart failure

ESC Professional Premium Access

The effects of combined hyperbaric oxygenation and erythropoietin therapy in treatment of heart failure

Session: Chronic heart failure - New treatments and trials

Topic: Multidisciplinary Interventions

Speaker: Professor P. Mitrovic (Belgrade, RS)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Predrag Mitrovic

School of Medicine, Belgrade University, Belgrade (Serbia)

0 follower

4 more presentations in this session

The I4RON-HF study, Intravenous Iron Isomaltoside for Inpatients veRsus Outpatient Asians with Heart Failure

Speaker: Doctor T. Lee (Kuala Lumpur, MY)

Myeloperoxidase as therapeutic target in HFpEF

Speaker: Doctor S. Lejeune (Brussels, BE)

First-in-man trial of b3-adrenoreceptor agonist treatment in chronic heart failure - impact on diastolic function

Speaker: Doctor H. Bahrami (Herlev, DK)

Chronic mitochondrial fusion promotor as a novel pharmacological intervention to alleviate left ventricular dysfunction in rats with chronic myocardial infarction

Speaker: Doctor C. Maneechote (Chiang Mai, TH)

Access the full session

Chronic heart failure - New treatments and trials

Speakers: Professor P. Mitrovic, Doctor T. Lee, Doctor S. Lejeune, Doctor H. Bahrami, Doctor C. Maneechote

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources